ENHERTU® Additional Analyses Further Reinforce Groundbreaking Efficacy in Patients with HER2 Positive Metastatic Breast Cancer
DESTINY-Breast03 data presented at SABCS 2021 showed Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated a similar benefit in patient subgroups, including...

Nabeela Syed flips the Illinois seat Republicans spent a record sum to keep
Court-martial proceedings begin against two Navy officers over INS Brahmaputra capsize
Cabinet grants Agniveers two more years and a wider route into regular forces
Zverev’s No. 1 debut ends in straight sets: what the Musetti loss actually says
SSC CGL answer key 2026 gives candidates a response sheet to audit, not a result to trust 

















